Updated US hepatic warnings for all diclofenac sodium products
This article was originally published in Scrip
Executive Summary
The prescribing information for all diclofenac-containing products in the US has been updated at the request of the US FDA. The update pertains to expanded warnings and precautions on the risk of elevations in liver enzymes during treatment.